SNX9 and diabetes mellitus: Collagen I and III immunohistochemistry results were consistent with those of Masson's staining, showing ample and well‐organized collagen fibers in the SNX9 inhibitor‐treated groups, indicating higher levels of collagen deposition than in the Diabetes and hgMDV groups, which promotes wound healing and improves tissue tensile strength.